GS
MXCT icon

Gagnon Securities’s MaxCyte MXCT Stock Holding History

Gagnon Securities’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,048,318
Closed -$2.86M – 93
2025
Q1 		$2.86M Buy
1,048,318
+850,992
+431% +$3.36M 0.63% 37
2024
Q4 		$821K Buy
197,326
+138,257
+234% +$523K 0.17% 52
2024
Q3 		$230K Buy
59,069
+2,563
+5% +$10.8K 0.05% 81
2024
Q2 		$222K Buy
56,506
+164
+0.3% +$706 0.05% 82
2024
Q1 		$236K Sell
56,342
-359
-0.6% -$1.69K 0.06% 81
2023
Q4 		$266K Buy
56,701
+1,264
+2% +$4.92K 0.06% 73
2023
Q3 		$173K Buy
55,437
+9,346
+20% +$37.6K 0.04% 86
2023
Q2 		$212K Buy
46,091
+9,194
+25% +$42.3K 0.04% 89
2023
Q1 		$183K Buy
36,897
+2,429
+7% +$12K 0.04% 101
2022
Q4 		$188K Buy
+34,468
New +$211K 0.04% 100

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gagnon Securities's MXCT Position: Q2 2025 in Review

Gagnon Securities sold out of MaxCyte (MXCT) in Q2 2025, closing a stake of 1,048,318 shares — an estimated $2.86M sold.

Gagnon Securities first reported a position in MXCT in Q4 2022 and held it in 10 quarters. The position peaked at $2.86M in Q1 2025. 120 funds tracked by Wall St. Rank hold MXCT as of Q2 2025.

  • Gagnon Securities reported no remaining MaxCyte position as of Q2 2025 after selling out during the quarter.
  • Gagnon Securities sold 1,048,318 MaxCyte shares in Q2 2025, an estimated $2.86M.
  • Gagnon Securities first reported a position in MaxCyte in Q4 2022 and held it in 10 quarters.
  • Gagnon Securities's MaxCyte position peaked at $2.86M in Q1 2025.
  • 120 funds tracked by Wall St. Rank held MaxCyte as of Q2 2025.

Based on Gagnon Securities's 13F filing for Q2 2025, filed 23 Jul 2025.